최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Experimental cell research, v.361 no.1, 2017년, pp.9 - 18
Mytilinaiou, Maria (Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete) , Nikitovic, Dragana (Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete) , Berdiaki, Aikaterini (Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete) , Papoutsidakis, Antonis (Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete) , Papachristou, Dionysios J. (Laboratory of Toxicology, School of Medicine, University of Crete) , Tsatsakis, Aristidis (Laboratory of Anatomy-Histology-Embryology, Unit of Bone and Soft Tissue Studies, School of Medicine, University of Patras, Patras) , Tzanakakis, George N. (Laboratory of Anatomy-Histology-Embryology, School of Medicine, University of Crete)
Abstract Fibrosarcoma is a tumor of mesenchymal origin, originating from fibroblasts. IGF-I is an anabolic growth factor which exhibits significant involvement in cancer progression. In this study, we investigated the possible participation of syndecan-2 (SDC-2), a cell membrane heparan sulfate (HS...
Ultrastruct. Pathol. Franchi 37 9 2013 10.3109/01913123.2012.670017 The contribution of electron microscopy to the characterization of soft tissue fibrosarcomas
Am. J. Surg. Pathol. Bahrami 34 1504 2010 10.1097/PAS.0b013e3181ef70b6 Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period
Am. J. Orthop. Papagelopoulos 31 253 2002 Clinicopathologic features, diagnosis, and treatment of fibrosarcoma of bone
Indian J. Dent. Res.: Off. Publ. Indian Soc. Dent. Res. Wadhwan 21 295 2010 10.4103/0970-9290.66640 Fibrosarcoma of the oral cavity
IUBMB life Mytilinaiou 65 134 2013 10.1002/iub.1112 Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells
J. Cell. Physiol. Fiorelli 226 2997 2011 10.1002/jcp.22645 Interplay between steroid receptors and neoplastic progression in sarcoma tumors
Mol. Nutr. Food Res. Hwang 55 594 2011 10.1002/mnfr.201000292 Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling
Int. J. Biochem. Cell Biol. Fthenou 38 2141 2006 10.1016/j.biocel.2006.06.006 Chondroitin sulfate A chains enhance platelet derived growth factor-mediated signalling in fibrosarcoma cells
Curr. Med. Chem. Nikitovic 20 2868 2013 10.2174/0929867311320230003 Could growth factor-mediated extracellular matrix deposition and degradation offer the ground for directed pharmacological targeting in fibrosarcoma?
J. Appl. Physiol. Nielsen 116 42 2014 10.1152/japplphysiol.01084.2013 Increase in tendon protein synthesis in response to insulin-like growth factor-I is preserved in elderly men
Int. J. Endocrinol. Hull 2014 234014 2014 10.1155/2014/234014 Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions
BioMed. Res. Int. Brahmkhatri 2015 538019 2015 10.1155/2015/538019 Insulin-like growth factor system in cancer: novel targeted therapies
Endocrinology Gallagher 152 2546 2011 10.1210/en.2011-0231 Minireview: IGF, insulin, and cancer
J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. Maki 28 4985 2010 10.1200/JCO.2009.27.5040 Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer
Endocr. Rev. Samani 28 20 2007 10.1210/er.2006-0001 The role of the IGF system in cancer growth and metastasis: overview and recent insights
Lancet Oncol. Balamuth 11 184 2010 10.1016/S1470-2045(09)70286-4 Ewing's sarcoma
Lancet Oncol. Furstenberger 3 298 2002 10.1016/S1470-2045(02)00731-3 Insulin-like growth factors and cancer
Cancer Lett. LeRoith 195 127 2003 10.1016/S0304-3835(03)00159-9 The insulin-like growth factor system and cancer
J. Natl. Cancer Inst. Sekyi-Otu 86 628 1994 10.1093/jnci/86.8.628 Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement
Breast Cancer Zielinska 7 9 2015 Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?
Cytokine Peplow 62 1 2013 10.1016/j.cyto.2013.02.015 A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration
Mol. Med. Rep. Zhou 12 3381 2015 10.3892/mmr.2015.3869 GSK1904529A, an insulin-like growth factor-1 receptor inhibitor, inhibits glioma tumor growth, induces apoptosis and inhibits migration
Oncotarget Bieghs 7 48732 2016 10.18632/oncotarget.8982 The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
Crit. Rev. Oncol./Hematol. Armakolas 108 137 2016 10.1016/j.critrevonc.2016.11.004 The role of the IGF-1 Ec in myoskeletal system and osteosarcoma pathophysiology
Li 52 1888 2012 Superoxide plays critical roles in electrotaxis of fibrosarcoma cells via activation of ERK and reorganization of the cytoskeleton, free radical biology & medicine
Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. Nam 55 106 2013 10.1016/j.fct.2012.12.050 Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells
J. Biol. Chem. Williams 286 43405 2011 10.1074/jbc.M111.297069 Phosphorylation of membrane type 1-matrix metalloproteinase (MT1-MMP) and its vesicle-associated membrane protein 7 (VAMP7)-dependent trafficking facilitate cell invasion and migration
PloS One Subramani 9 e97016 2014 10.1371/journal.pone.0097016 Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis
Matrix Biol.: J. Int. Soc. Matrix Biol. Skandalis 35 182 2014 10.1016/j.matbio.2013.09.002 Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans
Matrix Biol.: J. Int. Soc. Matrix Biol. Voudouri 56 95 2016 10.1016/j.matbio.2016.06.005 IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion
Curr. Oncol. Rep. Kolb 11 307 2009 10.1007/s11912-009-0043-1 Development of IGF-IR Inhibitors in Pediatric Sarcomas
Lancet Oncol. Olmos 11 129 2010 10.1016/S1470-2045(09)70354-7 Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
Cancer Res. Scotlandi 65 3868 2005 10.1158/0008-5472.CAN-04-3192 Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
Exp. Cell Res. Wang 317 367 2011 10.1016/j.yexcr.2010.10.015 Importance of syndecan-4 and syndecan −2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex
Worm Gopal 5 e1142042 2016 10.1080/21624054.2016.1142042 Redefining the role of syndecans in C. elegans biology
Exp. Cell Res. Vuoriluoto 314 3369 2008 10.1016/j.yexcr.2008.07.005 Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen
FEBS J. Afratis 284 27 2017 10.1111/febs.13940 Syndecans - key regulators of cell signaling and biological functions
Cancer Res. Park 65 9899 2005 10.1158/0008-5472.CAN-05-1386 Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells
Cancer Res. Orosco 67 3708 2007 10.1158/0008-5472.CAN-06-4164 Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma
Exp. Cell Res. Whiteford 313 3902 2007 10.1016/j.yexcr.2007.08.002 Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways
PloS One Peterfia 7 e39474 2012 10.1371/journal.pone.0039474 Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2
Cancer Rasheed 33 1027 1974 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z Characterization of a newly derived human sarcoma cell line (HT-1080)
Neoplasma Thurzo 23 577 1976 Human neoplastic cells in tissue culture: two established cell lines derived from giant cell tumor and fibrosarcoma
Biochim. Et. Biophys. Acta Kouvidi 1860 814 2016 10.1016/j.bbagen.2016.01.019 Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a beta-catenin/c-myc signaling axis
Oncol. Rep. Voudouri 36 2471 2016 10.3892/or.2016.5057 Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis
IUBMB life Chalkiadaki 63 109 2011 Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration
Cancer Lett. Chalkiadaki 312 235 2011 10.1016/j.canlet.2011.08.016 Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes
Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. Chitnis 14 6364 2008 10.1158/1078-0432.CCR-07-4879 The type 1 insulin-like growth factor receptor pathway
Mol. Cell. Endocrinol. Jeong 384 175 2014 10.1016/j.mce.2014.01.023 Insulin-like growth factor I induces proliferation and migration of porcine trophectoderm cells through multiple cell signaling pathways, including protooncogenic protein kinase 1 and mitogen-activated protein kinase
Mol. Cell. Endocrinol. Duan 206 75 2003 10.1016/S0303-7207(03)00212-0 The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2
Mol. Cancer Li 13 136 2014 10.1186/1476-4598-13-136 Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells
Mol. Med. Armakolas 21 167 2015 10.2119/molmed.2014.00222 Oncogenic role of the Ec peptide of the IGF-1Ec isoform in prostate cancer
FEBS Lett. Granes 547 212 2003 10.1016/S0014-5793(03)00712-9 Identification of a novel Ezrin-binding site in syndecan-2 cytoplasmic domain
J. Cell Sci. Granes 113 Pt 7 1267 2000 10.1242/jcs.113.7.1267 Ezrin links syndecan-2 to the cytoskeleton
J. Biol. Chem. Tang 284 27456 2009 10.1074/jbc.M109.033795 Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567
Nat. Rev. Mol. Cell Biol. Fehon 11 276 2010 10.1038/nrm2866 Organizing the cell cortex: the role of ERM proteins
Cell. Signal. Leiphrakpam 26 868 2014 10.1016/j.cellsig.2014.01.014 Ezrin expression and cell survival regulation in colorectal cancer
Anticancer Res. Dobra 23 2435 2003 Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells
FEBS J. Tsonis 280 2248 2013 10.1111/febs.12162 Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells
J. Cell Sci. Klass 113 Pt 3 493 2000 10.1242/jcs.113.3.493 Control of extracellular matrix assembly by syndecan-2 proteoglycan
Oncotarget Takahashi 6 4829 2015 10.18632/oncotarget.3104 Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-theta activation
PloS One Huang 10 e0133152 2015 10.1371/journal.pone.0133152 IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
Mol. Cell. Biochem. Yoon 223 1 2001 10.1023/A:1017549222677 Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells
Cancer Res. Tai 63 5850 2003 Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3′-kinase/AKT signaling
Bone Modrowski 37 180 2005 10.1016/j.bone.2005.04.010 Syndecan-2 overexpression induces osteosarcoma cell apoptosis: implication of syndecan-2 cytoplasmic domain and JNK signaling
Mol. Carcinog. Matsunaga 56 515 2017 10.1002/mc.22513 The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy
Int. J. Mol. Sci. Meister 14 4854 2013 10.3390/ijms14034854 Mitogen-activated protein (MAP) kinase scaffolding proteins: a recount
Cancer Res. Chen 69 9228 2009 10.1158/0008-5472.CAN-09-1950 Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression
Br. J. Cancer Thway 115 473 2016 10.1038/bjc.2016.214 Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells
Int. J. Surg. Pathol. Noujaim 24 5 2016 10.1177/1066896915606971 Histology-driven therapy: the importance of diagnostic accuracy in guiding systemic therapy of soft tissue tumors
Vopr. Onkol. Blizniukov 58 54 2012 [Pleomorphic fibrosarcoma]
Cancer Res. Dieudonne 70 5399 2010 10.1158/0008-5472.CAN-10-0090 High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells
Biochem. Biophys. Res. Commun. Contreras 286 742 2001 10.1006/bbrc.2001.5459 Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype
BMC Cell Biol. Vicente 14 25 2013 10.1186/1471-2121-14-25 Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts
Int. J. Biochem. Cell Biol. Essner 38 152 2006 10.1016/j.biocel.2005.08.012 Syndecan-2
J. Cell Sci. Bretscher 110 Pt 24 3011 1997 10.1242/jcs.110.24.3011 Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures
Mol. Biol. Cell Gary 6 1061 1995 10.1091/mbc.6.8.1061 Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site
J. Cell Sci. Zhou 118 4381 2005 10.1242/jcs.02559 Phosphorylation of ezrin on threonine 567 produces a change in secretory phenotype and repolarizes the gastric parietal cell
Cancer Res. Chen 69 8585 2009 10.1158/0008-5472.CAN-09-2284 Motor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasion
Reprod. Sci. Naftolin 14 101 2007 10.1177/1933719107301059 Estrogen-induced hypothalamic synaptic plasticity and pituitary sensitization in the control of the estrogen-induced gonadotrophin surge
Neoplasia Saygideger-Kont 18 111 2016 10.1016/j.neo.2016.01.002 Ezrin enhances EGFR signaling and modulates erlotinib sensitivity in non-small cell lung cancer cells
BMC Cancer Shannon 17 121 2017 10.1186/s12885-017-3107-x Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901
※ AI-Helper는 부적절한 답변을 할 수 있습니다.